en

PRODUCT DETAIL

Atazanavir Krka 300 mg tvrdé kapsuly

Code 1603D
MA number EU/1/19/1353/004
Product Form: cps dur 90 (3x30)x300 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: KRKA, d.d., Novo mesto, Slovenia
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AE Protease inhibitors
J05AE08 Atazanavir
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 25.03.2019
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.12.2023
eu-flag.png sk-flag.png